Trial sequential analysis confirmed that the evidence for LDL-C and insulin was sufficient to reach firm conclusions.<h4>Conclusion</h4>Probiotics have been shown to significantly reduce LDL-C and insulin levels in patients with CHD without increasing the risk of adverse events. Here, INS is linked to coronary artery disorder.